James D Smith1, Maeve A Lowery2, David Fell2, David J Gallagher3, Garrett M Nash4, Nancy E Kemeny2. 1. Department of Surgery, New York Presbyterian Hospital, Cornell University, New York. 2. Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York. 3. Department of Medical Oncology, Mater Misericordiea University Hospital, Dublin, Ireland. 4. Department of Surgery, Memorial Sloan Kettering Cancer Center, New York.
Abstract
BACKGROUND: An increasing proportion of patients are presenting with colorectal cancer at an early age. A proportion of these occur with genetic syndromes; however the majority present as sporadic. The purpose of this study is to investigate the prognosis and treatment of young patients with sporadic metastatic colorectal cancer. METHODS: Following IRB approval, patients with sporadic metastatic colorectal cancer at 40 years or under were identified. Patient charts and pathology reports were analyzed retrospectively for clinical and pathological factors. RESULTS: Three hundred and two patients were identified; 148 with liver metastases only, and 154 with extra-hepatic disease. Five-year overall survival was 19%, 28% for liver only disease, and 12% for extrahepatic disease. For patients with liver metastases only, factors associated with survival on univariable analysis included diagnosis in the 2000's, unilobular hepatic disease, smaller volume liver metastases, intrahepatic pump chemotherapy, resection of the primary, and resection of liver metastases. On multivariable analysis factors associated with survival included resection of the primary, resection of liver metastases, and diagnosis in the 2000's. CONCLUSION: Sporadic metastatic colorectal cancer in young patients appears to have a similar prognosis to that in older patients. The most significant prognostic factor was the ability to resect all sites of disease. J. Surg. Oncol. 2016;113:473-476.
BACKGROUND: An increasing proportion of patients are presenting with colorectal cancer at an early age. A proportion of these occur with genetic syndromes; however the majority present as sporadic. The purpose of this study is to investigate the prognosis and treatment of young patients with sporadic metastatic colorectal cancer. METHODS: Following IRB approval, patients with sporadic metastatic colorectal cancer at 40 years or under were identified. Patient charts and pathology reports were analyzed retrospectively for clinical and pathological factors. RESULTS: Three hundred and two patients were identified; 148 with liver metastases only, and 154 with extra-hepatic disease. Five-year overall survival was 19%, 28% for liver only disease, and 12% for extrahepatic disease. For patients with liver metastases only, factors associated with survival on univariable analysis included diagnosis in the 2000's, unilobular hepatic disease, smaller volume liver metastases, intrahepatic pump chemotherapy, resection of the primary, and resection of liver metastases. On multivariable analysis factors associated with survival included resection of the primary, resection of liver metastases, and diagnosis in the 2000's. CONCLUSION:Sporadic metastatic colorectal cancer in young patients appears to have a similar prognosis to that in older patients. The most significant prognostic factor was the ability to resect all sites of disease. J. Surg. Oncol. 2016;113:473-476.
Authors: Michael D'Angelica; Peter Kornprat; Mithat Gonen; Ronald P DeMatteo; Yuman Fong; Leslie H Blumgart; William R Jarnagin Journal: Ann Surg Oncol Date: 2010-11-02 Impact factor: 5.344
Authors: Dennis J Ahnen; Sally W Wade; Whitney F Jones; Randa Sifri; Jose Mendoza Silveiras; Jasmine Greenamyer; Stephanie Guiffre; Jennifer Axilbund; Andrew Spiegel; Y Nancy You Journal: Mayo Clin Proc Date: 2014-01-04 Impact factor: 7.616
Authors: Daniel T Chang; Rish K Pai; Lisa A Rybicki; Michael A Dimaio; Maneesha Limaye; Priya Jayachandran; Albert C Koong; Pamela A Kunz; George A Fisher; James M Ford; Mark Welton; Andrew Shelton; Lisa Ma; Daniel A Arber; Reetesh K Pai Journal: Mod Pathol Date: 2012-04-06 Impact factor: 7.842
Authors: Christine M Ribic; Daniel J Sargent; Malcolm J Moore; Stephen N Thibodeau; Amy J French; Richard M Goldberg; Stanley R Hamilton; Pierre Laurent-Puig; Robert Gryfe; Lois E Shepherd; Dongsheng Tu; Mark Redston; Steven Gallinger Journal: N Engl J Med Date: 2003-07-17 Impact factor: 91.245
Authors: Leonard B Saltz; Stephen Clarke; Eduardo Díaz-Rubio; Werner Scheithauer; Arie Figer; Ralph Wong; Sheryl Koski; Mikhail Lichinitser; Tsai-Shen Yang; Fernando Rivera; Felix Couture; Florin Sirzén; Jim Cassidy Journal: J Clin Oncol Date: 2008-04-20 Impact factor: 44.544
Authors: Nancy E Kemeny; Fidel D Huitzil Melendez; Marinela Capanu; Philip B Paty; Yuman Fong; Lawrence H Schwartz; William R Jarnagin; Dina Patel; Michael D'Angelica Journal: J Clin Oncol Date: 2009-05-26 Impact factor: 44.544
Authors: Rebecca A Barnetson; Albert Tenesa; Susan M Farrington; Iain D Nicholl; Roseanne Cetnarskyj; Mary E Porteous; Harry Campbell; Malcolm G Dunlop Journal: N Engl J Med Date: 2006-06-29 Impact factor: 91.245
Authors: V E P P Lemmens; N de Haan; H J T Rutten; H Martijn; O J L Loosveld; R M H Roumen; G J M Creemers Journal: Clin Exp Metastasis Date: 2011-01-05 Impact factor: 5.150